USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Mar 23, 2022 | Dec 2021 | $-0.81 | - | $-0.40 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Mar 23, 2022 | Dec 2021 | $0.00 | - | $0.00 |
Immunome, Inc's next earnings date is Wednesday, Mar 23, 2022 for the fiscal quarter ending Dec 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 1 | $-3.11 | $-3.11 | $-3.11 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2022 | 0 / 0 | $-1.86 | $-1.86 | $-1.86 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 1 | $0.00 | $0.00 | $0.00 |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Nov 15, 2021 | Sep 2021 | $-0.50 | - | - |
| Aug 16, 2021 | Jun 2021 | $-0.39 | $-0.46 | -17.95% |
| May 12, 2021 | Mar 2021 | $-0.41 | $-0.37 | 9.76% |
| Mar 25, 2021 | Dec 2020 | $-0.29 | $-0.40 | -37.93% |
| Nov 16, 2020 | Sep 2020 | $-0.40 | $-7.52 | -1780.00% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 25, 2021 | Dec 2020 | $-8.63 | $-7.92 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Nov 15, 2021 | Sep 2021 | $0.00 | - | - |
| Aug 16, 2021 | Jun 2021 | $0.00 | $500.00K | - |
| May 12, 2021 | Mar 2021 | $2.60M | $0.00 | - |
| Mar 25, 2021 | Dec 2020 | $2.10M | $0.00 | - |
| Nov 16, 2020 | Sep 2020 | $0.00 | $0.00 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 25, 2021 | Dec 2020 | $2.10M | $0.00 | - |
IMNM's next earnings date is Wednesday, Mar 23, 2022 for the fiscal quarter ending Dec 31, 2021.
According to analysts, the average EPS estimation for Immunome, Inc's next quarterly earnings is $-0.81, with a low EPS estimation of $-0.81, and a high estimation of $-0.81.
Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.44, the last 2 month trend is $-0.44, and the 3 month trend is $-0.44.
Based on analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.
Immunome, Inc's previous earnings date was Nov 15, 2021 for its fiscal quarter ended Sep 30, 2021.
Immunome, Inc's previous annual earnings date was Mar 25, 2021 for its fiscal year ended Dec 31, 2020.
IMNM's earnings per share (EPS) was $-7.92.
Revenues were $0.00.
The company reported a net income of $-17.84M.
Immunome, Inc reported a free cash flow of $-12.72M for its fiscal year, compared to $-9.83M a year ago.
The company ended the fiscal year with $613.00K in total debt, an increase of 8.69% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
